Results 221 to 230 of about 8,276 (254)

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Hepatology, 2020
Paolo Ventura, Manisha Balwani, David C Rees   +2 more
exaly  

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

New England Journal of Medicine, 2020
Manisha Balwani, Eliane Sardh, Paolo Ventura   +2 more
exaly  

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals

Journal of Internal Medicine, 2022
Mattias Lissing, Daphne Vassiliou, Ylva Floderus   +2 more
exaly  

Intermittent Acute Porphyria

New England Journal of Medicine, 1972
openaire   +2 more sources

Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria

Clinical Pharmacology and Therapeutics, 2020
Sagar Agarwal
exaly  

Givosiran: A Review in Acute Hepatic Porphyria

Drugs, 2021
exaly  

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Nature Medicine, 2018
Pedro Berraondo, Daniel Jericó, Lin T Guey   +2 more
exaly  

Intermittent acute porphyria.

Treatment services bulletin. Canada. Department of Veterans' Affairs, 2003
J A, LEROUX, N L, AUCKLAND
  +6 more sources

Acute Intermittent Porphyria

AJN, American Journal of Nursing, 1960
Charles A. Davis, Mollie G. Davis
openaire   +1 more source

Liver transplantation in the management of porphyria

Hepatology, 2014
Manish Thapar
exaly